pharmaceutical cleanroom technology europe · current equipment and methodologies for cleaning and...

4
08.30 Registration and Coffee 09.00 Chairman’s Opening Remarks James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society CLEANROOM DESIGN AND ENGINEERING VCCN SPOTLIGHT SESSION 09.10 Effective cleanroom HVAC systems • Evaluating the contamination removal efficiency by mechanical ventilation • Improving energy efficiency of HVAC systems • Developing technologies in HVAC control Koos Agricola, Contamination Control Expert, VCCN 09.50 Towards future proof high-tech facilities • What keeps pushing contamination control? • Distinctive trends in science, technologies and markets • New challenges and solutions (case studies) for cleanroom facility design • How contamination control could look like in 2050 Eric Stuiver, Chairman, VCCN 10.30 Morning Coffee 11.00 CFD as a Tool for Implementing Quality by Design in Pharmaceutical Cleanroom Projects • Introduction to CFD • CFD in the life-cycle of a pharmaceutical cleanroom project • CFD applied to the design of new cleanroom systems • CFD as a tool for trouble-shooting and design for remediation in existing systems • How CFD can help in the Commissioning and Qualification phases Pier Angelo Galligani, Past-President, Board Member, ASCCA ENVIRONMENTAL MONITORING AND CONTAMINATION CONTROL 11.40 Addressing new GMP Annex 1 requirements - selection of adequate cleanroom clothing that is part of efficient QRM system for aseptic manufacturing process • The different types of risks for quality linked with cleanroom garments • Elements to be considered in the risk assessment of cleanroom clothing • Mitigating the risks coming from cleanroom garments Steve Marnach, EMEA Training Manager & Critical Environments Sales and Marketing Specialist, DuPont 12.20 Aligning Standards and Best Practice in integrating Non-Viable and Viable Environmental Monitoring (EM) in GMP Cleanrooms (as part of a contamination control plan) • Applying ISO 14644-2:2015 for Non-Viable EM • Applying QRM and new concepts in the revision of ISO 14698 (prEN17141) for Viable EM • Challenges of integrating Non-Viable and Viable EM and real time vs indirect measurement • Applying 21CR 11 and Annex 11 to qualified EM systems for continuous and periodic EM Conor Murray, Chairman, Irish Cleanroom Society 13.00 Networking Lunch 14.00 Personnel, Premises and Cleanliness Requirements from a Quality Risk Management Approach – Annex 1 (2008) versus Draft Annex 1 (2017) • Cleanliness requirements today and in the future • Are operators needed in the future and to what extent? • Open systems, RABS, isolators or closed process system? • Operators in cleanrooms – Future problems or…? Matts Ramstorp, Professor in Cleanroom Technology, BioTekPro AB 14.40 Impact of the EU Biocidal Products Regulation 528/2012 on cleanroom disinfection • Background to EU Biocidal Products Regulation 528/2012 • Understand the regulation in more detail with regards to life science disinfectants • Explanation of the current situation with regards to common active ingredients • Impact of the BPR on cleanroom disinfectant users and how to prepare for it Siobhan Murphy, European Regulatory Specialist, Contec, Inc. 15.20 Afternoon Tea FRESENIUS KABI SPOTLIGHT SESSION 15.50 Contamination Control Elements for Manufacturing Units and Compounding Centers • Importance of design elements (e.g. design of cleanroom & equipment) for contamination control • Importance of procedural elements (e.g. cleaning & disinfection) for contamination control Tools to verify implemented contamination control elements are effective Challenges, case examples and areas to especially look for Alexander Stoll, Vice President, Head of Competence Centre of Microbiology and Aseptic Technique, Fresenius Kabi 16.30 Implementation of an aseptic mentoring program (AMP) in manufacturing sites • How it works, what are the targets and how to be successful • How to set it up, points to consider, aseptic mentors, how to perform audits for aseptic technique • Experiences & lessons learned Alana Poloni, Manager Microbiology & Aseptic Technique, Fresenius Kabi 17.10 Chairman’s Closing Remarks and Close of Day One Pharmaceutical Cleanroom Technology Europe Day One | Wednesday 9th October 2019 www.asdevents.com - www.asdevents.com/event.asp?id=20447

Upload: others

Post on 09-May-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pharmaceutical Cleanroom Technology Europe · current equipment and methodologies for cleaning and disinfection will be covered in detail • The topic of sterility relating to cleanroom

08.30 RegistrationandCoffee

09.00 Chairman’sOpeningRemarks

JamesDrinkwater,Chairman,PharmaceuticalandHealthcare

ScienceSociety

CLEANROOMDESIGNANDENGINEERING

VCCNSPOTLIGHTSESSION

09.10 EffectivecleanroomHVACsystems

• Evaluatingthecontaminationremovalefficiencyby

mechanical ventilation

• ImprovingenergyefficiencyofHVACsystems

• DevelopingtechnologiesinHVACcontrol

KoosAgricola,Contamination Control Expert, VCCN

09.50 Towardsfutureproofhigh-techfacilities

• Whatkeepspushingcontaminationcontrol?

• Distinctivetrendsinscience,technologiesandmarkets

• Newchallengesandsolutions(casestudies)forcleanroom

facility design

• Howcontaminationcontrolcouldlooklikein2050

EricStuiver,Chairman,VCCN

10.30 Morning Coffee

11.00 CFDasaToolforImplementingQualitybyDesignin

PharmaceuticalCleanroomProjects

• IntroductiontoCFD

• CFDinthelife-cycleofapharmaceuticalcleanroomproject

• CFDappliedtothedesignofnewcleanroomsystems

• CFDasatoolfortrouble-shootinganddesignforremediation

in existing systems

• HowCFDcanhelpintheCommissioningandQualification

phases

PierAngeloGalligani,Past-President,BoardMember,ASCCA

ENVIRONMENTALMONITORINGANDCONTAMINATIONCONTROL

11.40 AddressingnewGMPAnnex1requirements-selectionof

adequatecleanroomclothingthatispartofefficientQRMsystem

forasepticmanufacturingprocess

• Thedifferenttypesofrisksforqualitylinkedwithcleanroom

garments

• Elementstobeconsideredintheriskassessmentofcleanroom

clothing

• Mitigatingtheriskscomingfromcleanroomgarments

SteveMarnach,EMEATrainingManager&CriticalEnvironments

Sales and Marketing Specialist,DuPont

12.20 AligningStandardsandBestPracticeinintegratingNon-ViableandViableEnvironmentalMonitoring(EM)inGMPCleanrooms (aspartofacontaminationcontrolplan)• ApplyingISO14644-2:2015forNon-ViableEM• ApplyingQRMandnewconceptsintherevisionofISO14698(prEN17141)forViableEM

• ChallengesofintegratingNon-ViableandViableEMandrealtime vs indirect measurement

• Applying21CR11andAnnex11toqualifiedEMsystemsforcontinuous and periodic EM

ConorMurray,Chairman, IrishCleanroomSociety

13.00 NetworkingLunch

14.00 Personnel,PremisesandCleanlinessRequirementsfromaQualityRiskManagementApproach–Annex1(2008)versusDraftAnnex1(2017)• Cleanlinessrequirementstodayandinthefuture• Areoperatorsneededinthefutureandtowhatextent?• Opensystems,RABS,isolatorsorclosedprocesssystem?• Operatorsincleanrooms–Futureproblemsor…?MattsRamstorp,Professor in Cleanroom Technology,BioTekProAB

14.40 ImpactoftheEUBiocidalProductsRegulation528/2012oncleanroomdisinfection• BackgroundtoEUBiocidalProductsRegulation528/2012• Understandtheregulationinmoredetailwithregardstolife

science disinfectants• Explanationofthecurrentsituationwithregardstocommon

active ingredients• ImpactoftheBPRoncleanroomdisinfectantusersandhowto

prepare for itSiobhanMurphy,European Regulatory Specialist, Contec,Inc.

15.20 AfternoonTea

FRESENIUSKABISPOTLIGHTSESSION15.50 ContaminationControlElementsforManufacturing

UnitsandCompoundingCenters• Importanceofdesignelements(e.g.designofcleanroom&equipment)forcontaminationcontrol

• Importanceofproceduralelements(e.g.cleaning&disinfection)for contamination control

• Tools to verify implemented contamination control elementsare effective

• Challenges, case examples and areas to especially look forAlexanderStoll,Vice President, Head of Competence Centre of MicrobiologyandAsepticTechnique,FreseniusKabi

16.30 Implementationofanasepticmentoringprogram(AMP)inmanufacturingsites• Howitworks,whatarethetargetsandhowtobesuccessful• Howtosetitup,pointstoconsider,asepticmentors,howtoperformauditsforaseptictechnique

• Experiences&lessonslearnedAlanaPoloni,ManagerMicrobiology&AsepticTechnique,FreseniusKabi

17.10 Chairman’sClosingRemarksandCloseofDayOne

PharmaceuticalCleanroomTechnologyEurope DayOne|Wednesday9thOctober2019

www.asdevents.com - www.asdevents.com/event.asp?id=20447

Page 2: Pharmaceutical Cleanroom Technology Europe · current equipment and methodologies for cleaning and disinfection will be covered in detail • The topic of sterility relating to cleanroom

08.30 RegistrationandCoffee

09.00 Chairman’sOpeningRemarksJamesDrinkwater,Chairman,PharmaceuticalandHealthcareScienceSociety

CLEANROOMDESIGNANDENGINEERING

OPENINGADDRESS09.10 DevelopmentofAseptic-Containmentstrategies(ACS)for

processingofnewtoxic,potentorbio-hazardsterilemedicinalproductsandtherapies• RationalefordevelopmentofanAsepticContainmentstrategy(ACS)tositalongsidetheAnnex1ContaminationcontrolstrategyCCSrequiredforsterilemedicinalproductmanufacture

• Aseptic-ContainmentriskcharacterisationandriskcontrolcontainmentlevelsatHealthbasedexposurelevels

• ResearchintoAerosoldistributionandcontainmentinfillingsterile Toxic and Biohazard medicinal and therapy products in barrierandcombinedcleanroomtechnology

JamesDrinkwater,Chairman,PharmaceuticalandHealthcareScienceSociety

09.50 CleanroomCost,Quality,EnvironmentalSustainability–canIaffordtocompromise?Thepresentationwilldiscussthemanyoptionsopentocleanroomusers to minimise the energy consumption and operational costs ofthesehighlyenergyintensivespaces.Therearemanyefficiencyimprovementsavailablethathaveproventohavenodetrimentalimpactonthecriticalproductqualityneeds.Topicsdiscussedwillinclude:• Practical&proventoptipsyoucanapplytodaytomakeareal&significantimprovement

• HeadsuponISO14644part16• Thebusinesscasetosupportaction–illustratedwithcasestudies• FuturegamechanginginnovationincleanroomcontrolsKeithBeattie,Life Sciences Lead,EnergyEfficiencyLtd

10.30 Morning Coffee

11.00 HVAConagreenfieldfillingplantprojectfromCDtoValidation• Istheorganisationalstructureimportant?• HowcanweuseinterfaceagreementsforHVAC?• EnsuringflexibleandsimplevalidationBirgerLerche-Jorgensen,HVACResponsible,SME,ALK-AbellóNordicA/S

ENVIRONMENTALMONITORINGANDCONTAMINATIONCONTROL

11.40 Casestudy:WhathappenedinChinawiththecontaminatedWFIsystem?• Preventivemaintenanceofwatersystems• Correctiveversuspreventiveactions• Phenotypicversusgenotypicidentifications• RiskoffalsenegativetestwithendotoxinOlivierChancel,SterilityandAsepticProcessAssuranceExpert, BoehringerIngelheim

12.20 NetworkingLunch

TAKEDASPOTLIGHTSESSION

13.20 Implementationofaglobalcontamination

controlprogram–Afieldreport

• Overview:Fromtheideatotherolloutofaglobal

contaminationcontrolprogram(CCP)

• Contaminationcontrolprogramkeyelementsanddocuments

• Currentstatus/sustainphaseofthecontaminationcontrol

program

ChristophHansy,SRQCScientist,Takeda

14.00 Microbialcontaminationinvestigationtool

• Backgroundandadvantages

• Overviewandkeyelements

• Casestudy

ChristineArbesser-Rastburg,Director,GlobalMicrobiology,Takeda

14.40 AfternoonTea

15.10 Arisk-basedapproachtocleaninganddisinfection

• WillcovercurrentindustryregulationsintheUS,Europeand

Globallyrelatedtocleaninganddisinfection

• RegulatoryexpectationsincludingthelatestrevisionofAnnexI

andrecentFDAWarningLettersand483’srelatedtocleaning

and disinfection

• Cleaningfrequency,disinfectantrotation,rinsingandresidue

removal, disinfectant coverage calculations and the most

currentequipmentandmethodologiesforcleaningand

disinfectionwillbecoveredindetail

• Thetopicofsterilityrelatingtocleanroomdisinfectantsand

sporicideswillbeexplained

• Thissessionwillprovidetheabilitytodesignaneffectiverisk-

basedapproachtocleaninganddisinfection

JosephMcCall, Technical Services Specialist, STERISCorporation

15.50 Particlecontaminationmonitoringinhigh-techcleanrooms

•Particlecontaminationriskassessment

•Classificationversusmonitoringinparticlecontaminationcontrol

•Exampleofparticledepositionmonitoring

•Exampleofsurfaceparticlecontaminationcontrol

• Linkwithairbornebiocontamination

IsabelleTovena-Pecault,HeadofInternationalandEuropean

Projects,ALPHA-RLH

16.30 Chairman’sClosingRemarksandCloseofDayTwo

PharmaceuticalCleanroomTechnologyEuropeDayTwo|Thursday10thOctober2019

PharmaceuticalCleanroomTechnologyEuropeDayOne|Wednesday9thOctober2019 www.cleanroomtechnology.co.uk

Register online at www.cleanroomtechnology.co.uk

www.asdevents.com - www.asdevents.com/event.asp?id=20447

Page 3: Pharmaceutical Cleanroom Technology Europe · current equipment and methodologies for cleaning and disinfection will be covered in detail • The topic of sterility relating to cleanroom

EnvironmentalClassification,QualificationandMonitoringofGMPControlledareas

referencingISO14644-1andriskbasedGMPWorkshop Leader:

JamesDrinkwater,Chairman, PharmaceuticalandHealthcareScienceSociety

Overviewoftheworkshop:EU GMP Annex 1 differentiates Environmental classification,Qualification and risk based (holistic) monitoring of GMPcontrolled areas that are used in the manufacture of sterile medicines. ISO 14644-1 is generic forCleanroomclassificationsanditisnotalwaysclearhowtoapplyconsideringariskbasedGMP approach. Qualification extends through establishingenvironmental control through process simulations and media fills with strategies required or how to qualify Cleanrooms andBarrier technology (Isolators & RABS). EM programs require aholisticapproachconsideringriskbased/riskassessedsamplinglocationsthatareconnectedthroughallstagesofclassification,qualification and monitoring. This workshop explains therelationship and methodology for Classification, QualificationandEnvironmentalmonitoring.

Whyyoushouldattend?• ClassificationofGMPcontrolledareaswithafocuson0.5micron

particlesizesisaGMPrequirementandreferencedinAnnex1butitisnotalwaysclearonhowISO14644-1isapplied.

• Qualificationcombinesparticlesizesof0.5and5.0micronplusnottoexceedmicrobiologicallevels(surfaceandairborne)andrequiresrationale.ConsiderationprovidedtothePHSSrationale(reviewedbytheMHRA).

• Environmentalmonitoringdataiscriticaltosterileproductreleaseasevidencesterileproductshavenotbeencontaminatedfromtheprocessingenvironment.Currentbestpracticeisexplainedincluding rationales for monitoring environments that may containtoxicorbiologicallyactivesterileproductsortherapies.

Agenda:

08.30 Registration & Coffee

09.00 Workshopleaderintroduction

09.10 Session1-EnvironmentalClassificationofGMPcontrolledareas•ISO14644-1applicationinGMPcleanroomclassification•Classificationsamplingpositions–riskbased•ClassificationofCleanroomsandBarrierGMPZones–whydifferentapproachesarerequired

09.50 Session2-EnvironmentalQualification•GMPComplianceenvironmentalqualificationconsidering1m3samplevolumes

•Environmentalqualificationstart-uptostateofcontrolincludingmicrofloracharacterisation,operational monitoring

•Environmentalqualificationthroughprocesssimulations and Media Fills

10.30 CoffeeBreak

11.00 Session3-Riskbasedenvironmentalmonitoringmethods,programanddatatrending•EMriskassessmentsforsamplelocationsandsample

type •EMprograms:management,structureanddata

processing •PerspectiveonuseofRapidMicroMethods:RMM

11.40 Session4-Casestudy:EnvironmentalClassification,QualificationandRiskbasedmonitoringofavial/syringeFillinglineandrelationshipwithContaminationControlStrategy:CCSforEUGMPAnnex1compliance•OverviewofCasestudy:BiologicalproductVial/SyringeFillingLineinIsolatorBarriertechnologywithuse of pre-sterilised containers transferred to Grade AasepticprocessingzoneviaNTT:No-touch-transfertechnology

•OverviewofRationaleforEnvironmentalClassification,QualificationandMonitoringfortheAsepticprocessingfillingzonesandsurroundingCleanroom

•ApplicationofQRM:QualityRiskManagementappliedwhereapplicationvariesfromconventional/generic GMP

12.20 Closingremarks

12.30 Endofworkshop

AbouttheworkshopleaderJames Drinkwater is a pharmaceutical process engineer with additional education inpharmaceuticalmicrobiology.Havingspent10yearsin the pharma industry (Amersham-GE Healthcare)Jameshaddirector rolesatbarrier technologyandhydrogen peroxide vapor generator companies

achievingsubjectmatterexpertstatus.CurrentrolesincludeHeadofGMPcomplianceandAsepticprocesssupportforFZielGmbH,thelargestIsolatorandRABSmanufacturerinGermanyworkingonmajorfillinglineprojectsandindependentlyanelectedroleasChairmanofthePHSS:Pharmaceutical&HealthcareSciencesSociety and leader of the PHSS Aseptic processing, Aseptic-ContainmentandAnnex1focusgroups.

Aboutthecompany:At F Ziel the role includesprocess integrationofenvironmentalcontrol barrier systems with sterile product aseptic processingand support for GMP compliance including environmental controlandmonitoringriskassessments.ThePHSSisaNotforProfiteducational platform for GMP providing supportive guidance in the form of technical monographs, impact statements and Clarity on GMP guidance notes. PHSS provide workshop andtrainingcourses in theUKhavinga strongconnectionwith theUKMHRA.

HALF-DAYPRE-CONFERENCEWORKSHOPATuesday8thOctober2019

CopthorneTaraHotel,CentralLondon,UK08.30–12.30

www.asdevents.com - www.asdevents.com/event.asp?id=20447

Page 4: Pharmaceutical Cleanroom Technology Europe · current equipment and methodologies for cleaning and disinfection will be covered in detail • The topic of sterility relating to cleanroom

HALF-DAYPRE-CONFERENCEWORKSHOPBTuesday8thOctober2019

CopthorneTaraHotel,CentralLondon,UK13.30–17.30

GowningTheory andBestPracticeImplementation

Workshop Leaders: ConorMurray,Chairman, IrishCleanroomSocietyMattsRamstorp,Professor in Cleanroom Technology,

BioTekProAB

WorkshopOverview:Thiswillbeinteractiveworkshopcombiningtheoryandpractice,wherebestpracticePALdesignandconfigurationwillbeoutlinedalongwithpresentingthetheoryofgowningandselectioncriteria,coupled with participation by attendees in getting real worldexperienceofdifferentgowningtechniquesforasepticprocessingandterminalsterilisationGMPapplications.

Whyshouldyouattend:• Howtosetuserrequirements• UnderstandPAL/Gowningspaceplanningandconfiguration

fordifferentGMPclassifications• Getaninsightintothescience,experimentaldataandissues

aroundlaunderedvsreusablevslimitedusegowns• UnderstandhowGowningmaterialsareassessedand

monitoredduringuse(EM)• Gainpracticalexperienceingowninganddegowning,

AsepticvsNonAseptictechniques

Agenda:

13.30 Registration & Coffee

14.00 Openingremarksandintroductions

14.10 Session1-THEORYSettingRequirements& Gowning/PALPlanning• Settinguserrequirements•Spaceplanningdesign&configurationstomeetdifferentclassifications-establishingcontrol

•EM considerations - demonstrating control

14.50 Session2-THEORYGowningSelectionCharacteristics ofdifferenttypesGownmaterials•Testing methods•Experimental test data•Selection criteria and considerations•GowningvsDegowningdifferences

15.30 TeaBreak

16.00 Session3-THEORY&PRACTICALGowning•ImportanceofHygiene•PreparationforGowning•HandWashingtechniqueanddemonstration

16.30 Session4-PRACTICALGowningApplications•Asepticprocessingvsterminalsterilisation

applications•Gowningexercises•Degowningexercises

17.20 Closingremarks

17.30 Endofworkshop

AbouttheWorkshopLeaders:ConorMurrayhasover30years’experienceindesignand construction of cleanrooms and biosafetylabs,and since 2007 independently inanoversightand auditing role. Conor represents the NationalStandards Authority of Ireland (NSAI), as Head ofDelegation and SME at ISO TC 209 on cleanroom

standardisation. Conor is Convenor of WG-05 in CEN TC243andadvises the Irish Health Service.Conor isChairmanof theIrish Cleanrooms Society (ICS) and a past Chairman of theInternationalConfederationofContaminationControlSocieties,(ICCCS). Conor lectures internationally and gives cleanroomtrainingandeducationcoursesonbehalfoftheICS.

MattsRamstorp has beenworking formore than 30yearswithcleanlinessandhygieneasaresearcher,consultant, and educator. Matts is a Master ofScience in Chemical Engineering, Technology Doctor of Applied Biochemistry (Biotechnology)and Professor of Renewable Engineering and

ProductionHygieneatLTH,LundUniversityofTechnology.Mattshasalsopublishedanumberofbooksinthefieldofcleanroomtechnology.

www.asdevents.com - www.asdevents.com/event.asp?id=20447